Integra LifeSciences Holdings Corporation (IART)
- Previous Close
28.41 - Open
28.42 - Bid 28.27 x 200
- Ask 28.40 x 200
- Day's Range
28.25 - 28.81 - 52 Week Range
27.18 - 56.21 - Volume
142,520 - Avg. Volume
769,611 - Market Cap (intraday)
2.227B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
33.73 - EPS (TTM)
0.84 - Earnings Date May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
44.40
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
www.integralife.comRecent News: IART
Performance Overview: IART
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IART
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IART
Valuation Measures
Market Cap
2.23B
Enterprise Value
3.61B
Trailing P/E
33.82
Forward P/E
8.88
PEG Ratio (5yr expected)
0.74
Price/Sales (ttm)
1.48
Price/Book (mrq)
1.41
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
14.09
Financial Highlights
Profitability and Income Statement
Profit Margin
4.39%
Return on Assets (ttm)
4.24%
Return on Equity (ttm)
3.99%
Revenue (ttm)
1.54B
Net Income Avi to Common (ttm)
67.74M
Diluted EPS (ttm)
0.84
Balance Sheet and Cash Flow
Total Cash (mrq)
309.1M
Total Debt/Equity (mrq)
106.02%
Levered Free Cash Flow (ttm)
177.7M
Research Analysis: IART
Company Insights: IART
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: IART
Analyst Report: Integra Lifesciences Hldgs Cor
Based in Princeton, New Jersey, Integra is a medical device company that develops and markets devices for use in neurosurgery, nerve repair, and skin and wound repair. The company's products are used in cranial and spinal procedures, peripheral nerve repair, the repair of skin and deeper tissue from burns and vehicular accidents, and the repair and reconstruction of soft tissue. The company has two segments: Codman Specialty Surgical and Tissue Technologies. It also sells products through private-label relationships with other medical device companies.
RatingPrice TargetMarket Update: BAC, IART, MS, SCHW, SWX
Stocks were mixed on Tuesday morning as investors digested earning reports. Starts of residential units fell to a seasonally adjusted annual rate of 1,321,000 in March, a 14.7% decline from February's revised rate and well short of expectations. Building permits issued also slipped to an annualized 1,458,000, a 4.3% decline from February and also short of expectations. Housing starts declined in all regions with the exception of the West, which rose 7.1%. Building permits issued were flat for units of five or more homes per building, while declining 10.3% for buildings of two to four units, and 5.7% for single-family homes. Regionally, permits issued fell in the Northeast (-20.8%), Midwest (-14.7%), and South (-0.6%), while growing in the West (+5.1%). The Dow was up 0.4%, while the S&P 500 was flat and the Nasdaq rose 0.1%. Crude oil is trading near above $85 per barrel and gold rose $22 to $2405 per ounce.
Analyst Report: Integra Lifesciences Hldgs Cor
Based in Princeton, New Jersey, Integra is a medical device company that develops and markets devices for use in neurosurgery, nerve repair, and skin and wound repair. The company's products are used in cranial and spinal procedures, peripheral nerve repair, the repair of skin and deeper tissue from burns and vehicular accidents, and the repair and reconstruction of soft tissue. The company has two segments: Codman Specialty Surgical and Tissue Technologies. It also sells products through private-label relationships with other medical device companies.
RatingPrice TargetMarket Update: AEP, IART, SJM
Stocks were little changed on Friday morning following comments by New York Fed President John Williams that talk of rate cuts is 'premature.' Meanwhile, according to the Empire State Manufacturing Survey, the December manufacturing index dropped 24 points to -14.5 from +9.1 in November. On the earnings front, shares of Costco rose more than 3% after it reported above-consensus fiscal 1Q results. The Dow rose 0.1%, the S&P 500 gained 0.1% and the Nasdaq was up 0.5%. Crude oil traded near $71 per barrel, while gold rose $5 to $2050 per ounce.